All the funding deals in the synthetic biology market
Download our beautiful pitch about the synthetic biology market
In our synthetic biology market deck, you will find everything you need to understand the market
The synthetic biology market is attracting funding across healthcare, food, agriculture, chemicals, materials, and biotechnology tools.
We conducted deep research and collected 67 synthetic biology funding deals announced between 2024 and June 2026.
We refresh this page very often to include newly announced synthetic biology funding deals.
And if you want to better understand this new industry, you should get our beautiful slides covering the synthetic biology market.
Insights
- The 67 synthetic biology funding deals in this list represent more than $1.70 billion in disclosed investment between 2024 and June 2026.
- Synthetic biology companies raised about $643 million in 2024 and $789 million in 2025. The higher 2025 total was supported by several large healthcare rounds.
- The synthetic biology market recorded $276 million across 17 disclosed deals during the first half of 2026.
- Healthcare and programmable biology attracted many of the largest rounds. EvolutionaryScale, Profluent, Stylus Medicine, and Azalea Therapeutics each raised more than $80 million.
- AI is becoming a central part of the synthetic biology market. Companies use AI to design proteins, enzymes, cells, crops, and biological production systems.
- Precision fermentation remains an important funding category. Funded companies are developing dairy proteins, egg proteins, fats, oils, sweet proteins, and food ingredients.
- Industrial synthetic biology is expanding beyond food. Several companies are engineering organisms or enzymes to produce chemicals, fuels, textiles, rubber, surfactants, and other materials.
- Investors are also backing synthetic biology infrastructure. DNA synthesis, laboratory automation, fermentation systems, cell programming, and bioprocess scale-up all received funding.
- Several synthetic biology companies raised capital more than once during the period. Profluent, Antheia, baCta, and Standing Ovation each announced separate funding rounds.
- Funding is spread across North America, Europe, Asia-Pacific, Africa, and the Middle East, showing that the synthetic biology market is becoming increasingly global.
This chart, featured in our synthetic biology market deck, illustrates yearly VC funding for synthetic biology startups
Summary table of the funding deals for the synthetic biology market since 2024
We define the synthetic biology market as the set of tools, platforms, and products that rely on engineering biological systems using designed DNA, genetic circuits, or engineered organisms.
We include specialized synbio tools and software, biofoundry and automation platforms, and end-use applications in areas like food, agriculture, health, chemicals, and materials where synthetic biology is a core part of how the product is created or performs.
We exclude conventional biotech and pharmaceuticals, basic GMOs, and traditional fermentation or bio-based products where modern synthetic biology methods are not central to the design or production process.
We focused exclusively on pure players, defined as companies with at least 70–80% of their business directly tied to the synthetic biology market.
Our analysis has been done at a global level with a minimum funding threshold of $300k.
You can also read our detailed analysis to understand how funding activity in the synthetic biology market has evolved recently.
If you want a longer-term view, we also have a study of how funding activity in the synthetic biology market has changed over the years.
Also, you should know that we have a dedicated page, updated weekly, with all the latest fundraising deals in the synthetic biology market.
| Name | What they do | Amount in $ | Quarter | Source(s) |
|---|---|---|---|---|
| Syntax Bio | Programs advanced cell therapies through a computational cell-development platform | $14.4M | Q2 2026 | FinancialContent |
| Portal Biotechnologies | Provides cell-engineering tools for drug discovery and cell therapy development | $9.0M | Q2 2026 | Business Wire |
| StrainX Bioworks | Uses synthetic biology and precision fermentation to produce proteins and ingredients | $13.0M | Q2 2026 | Protein Production Technology |
| Melazyme | Uses precision fermentation to produce melanin and sweet proteins | $2.0M | Q2 2026 | Green Queen |
| Fermeate | Uses light to control gene activity during industrial fermentation | $2.0M | Q2 2026 | Business Wire |
| Clean Food Group | Produces yeast-based oils and fats for food, cosmetics, and pet nutrition | $6.1M | Q2 2026 | Business Wire |
| Standing Ovation | Produces animal-free casein through precision fermentation | $28.5M | Q1 2026 | TMCnet |
| Cauldron Ferm | Develops continuous fermentation systems for large-scale biomanufacturing | $13.25M | Q1 2026 | Cauldron |
| Rubi | Uses cell-free enzymes to convert carbon dioxide into materials | $7.5M | Q1 2026 | PR Newswire |
| baCta | Programs microbes to produce industrial ingredients using AI and synthetic biology | $7.6M | Q1 2026 | Tech.eu |
| Verley | Produces dairy proteins through precision fermentation | $30.0M | Q1 2026 | AgFunderNews |
| Twogee Biotech | Engineers enzymes and microbes that convert biomass into useful raw materials | $2.35M | Q1 2026 | HTGF |
| Antheia | Uses engineered yeast to manufacture pharmaceutical ingredients | $24.0M | Q1 2026 | Antheia |
| Think Bioscience | Uses synthetic biology to discover medicines for difficult biological targets | $55.0M | Q1 2026 | PR Newswire |
| Anzen Industries | Develops cell-free enzyme reactors for chemical production | $2.2M | Q1 2026 | Tech.eu |
| bit.bio | Programs human cells for drug discovery and therapeutic development | $50.0M | Q1 2026 | bit.bio |
| Biographica | Uses AI to identify gene-editing targets for crop development | $9.5M | Q1 2026 | AgFunderNews |
| Immobazyme | Produces enzymes, growth factors, biologics, and biotechnology ingredients | $1.45M | Q4 2025 | Techloy |
| Melt&Marble | Produces designed fats through precision fermentation | $8.5M | Q4 2025 | Green Queen |
| Aether Biomachines | Creates industrial and material products using AI-designed proteins | $15.0M | Q4 2025 | Business Wire |
| Profluent | Builds AI models that design proteins and genome-editing systems | $106.0M | Q4 2025 | Business Wire |
| Erg Bio | Converts biomass waste into fuel ingredients and important chemicals | $6.5M | Q4 2025 | Erg Bio |
| Number 8 Bio | Develops engineered feed ingredients that reduce livestock methane emissions | $7.18M | Q4 2025 | Startup Daily |
| The EVERY Company | Produces functional egg proteins through precision fermentation | $55.0M | Q4 2025 | The EVERY Company |
| Azalea Therapeutics | Engineers therapeutic cells directly inside the human body | $82.0M | Q4 2025 | GlobeNewswire |
| Nutropy | Produces animal-free casein for cheese and dairy products | $8.1M | Q4 2025 | Green Queen |
| Asterix Foods | Uses plant cells to manufacture valuable bioactive proteins | $4.2M | Q4 2025 | Business Wire |
| Ansa Biotechnologies | Provides enzymatic DNA synthesis for research and medicine development | $54.4M | Q4 2025 | Ansa Biotechnologies |
| Scindo | Uses AI to discover and design enzymes for sustainable chemistry | $5.4M | Q3 2025 | Scindo |
| NetZeroNitrogen | Develops bacterial seed treatments that help crops use atmospheric nitrogen | $6.6M | Q3 2025 | World Fund |
| Provectus Algae | Programs algae to produce feed ingredients that reduce methane emissions | $10.1M | Q3 2025 | AgFunderNews |
| AmphiStar | Produces microbial surfactants from biological industrial side streams | $11.7M | Q3 2025 | European Biotechnology |
| Antheia | Uses engineered yeast to manufacture pharmaceutical ingredients | $56.0M | Q2 2025 | Antheia |
| Solena Materials | Uses AI and engineered microbes to produce protein-based textile fibres | $6.7M | Q2 2025 | Imperial College London |
| Stylus Medicine | Develops genetic medicines using engineered recombinases and targeted delivery | $85.0M | Q2 2025 | Business Wire |
| Trilobio | Builds automated laboratory systems for biology research workflows | $8.0M | Q2 2025 | SynBioBeta |
| Grove Biopharma | Develops engineered biologic medicines for difficult intracellular targets | $30.0M | Q2 2025 | Business Wire |
| Synthetic Design Lab | Designs engineered proteins for next-generation antibody-drug conjugates | $20.0M | Q2 2025 | Business Wire |
| INTAKE | Produces yeast-based proteins for meat, dairy, and egg alternatives | $9.2M | Q2 2025 | World Bio Market Insights |
| Differential Bio | Uses AI and automation to improve biomanufacturing scale-up | $2.2M | Q1 2025 | Protein Production Technology |
| Arbor Biotechnologies | Develops genetic medicines using CRISPR and related gene-editing systems | $73.9M | Q1 2025 | Arbor Biotechnologies |
| Vivici | Produces dairy proteins through precision fermentation | $33.7M | Q1 2025 | AgFunderNews |
| Oobli | Produces sweet proteins through precision fermentation as sugar alternatives | $18.0M | Q1 2025 | FoodBev Media |
| Latent Labs | Builds AI models for programmable biology and protein design | $50.0M | Q1 2025 | Latent Labs |
| Enduro Genetics | Programs production cells to improve industrial biomanufacturing yields | $12.4M | Q1 2025 | Enduro Genetics |
| Esphera SynBio | Develops engineered exosome vaccines and immunotherapies | $2.0M | Q1 2025 | PR Newswire |
| Cradle | Uses AI and laboratory testing to engineer improved proteins | $73.0M | Q4 2024 | Cradle |
| Anthrogen | Engineers microbes and enzymes to convert carbon dioxide into chemicals and fuels | $4.0M | Q4 2024 | SynBioBeta |
| Aurealis Therapeutics | Develops engineered cell and gene therapies for wounds and cancer | $9.1M | Q4 2024 | Aurealis Therapeutics |
| baCta | Uses engineered microorganisms to produce carbon-negative natural rubber | $3.6M | Q4 2024 | EU-Startups |
| Integrated Biosciences | Uses synthetic biology and machine learning to develop age-related medicines | $17.2M | Q4 2024 | Business Wire |
| Enzymit | Uses designed enzymes for cell-free biological production | $10.0M | Q3 2024 | CTech |
| Constructive Bio | Engineers custom genomes and creates new biological molecules | $58.0M | Q3 2024 | Constructive Bio |
| Standing Ovation | Produces animal-free casein through precision fermentation | $4.1M | Q3 2024 | Edible Planet |
| Abolis Biotechnologies | Engineers microorganisms to produce industrial and microbiome ingredients | $37.8M | Q3 2024 | Abolis Biotechnologies |
| SOLASTA Bio | Develops peptide-based insect-control products for agriculture | $14.0M | Q3 2024 | SOLASTA Bio |
| Biomatter | Uses generative AI to design new enzymes | $7.0M | Q3 2024 | Biomatter |
| GRO Biosciences | Creates protein medicines using an expanded set of amino acids | $60.3M | Q3 2024 | Business Wire |
| Again | Uses engineered microbes to convert carbon dioxide and hydrogen into chemicals | $43.0M | Q3 2024 | Chemical & Engineering News |
| EvolutionaryScale | Builds AI foundation models for protein design and programmable biology | $142.0M | Q2 2024 | SynBioBeta |
| Radar Therapeutics | Develops programmable medicines controlled by molecular RNA sensors | $13.4M | Q2 2024 | Business Wire |
| Allozymes | Discovers and engineers enzymes using high-throughput testing | $15.0M | Q2 2024 | PR Newswire |
| Elegen | Produces synthetic DNA using a cell-free manufacturing process | $35.0M | Q2 2024 | Elegen |
| Insempra | Creates biological ingredients for food, beauty, materials, and textiles | $20.0M | Q2 2024 | Insempra |
| Onego Bio | Produces animal-free egg protein through precision fermentation | $30.0M | Q2 2024 | Onego Bio |
| Profluent | Uses AI to design proteins and gene-editing systems | $35.0M | Q1 2024 | Business Wire |
| Tierra Biosciences | Uses AI-guided cell-free systems to produce custom proteins | $11.4M | Q1 2024 | Pulse 2.0 |
This market map, featured in our synthetic biology market deck, highlights top companies and startups in the synthetic biology market
Related blog posts
- The latest changes in the synthetic biology market
- The most recent news in synthetic biology
- How large is the synthetic biology market today?
- The most recent funding news in synthetic biology
